GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Change In Receivables

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Change In Receivables?

Wanbangde Pharmaceutical Holding Group Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Wanbangde Pharmaceutical Holding Group Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Wanbangde Pharmaceutical Holding Group Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-15 Mil. It means Wanbangde Pharmaceutical Holding Group Co's Accounts Receivable increased by ¥15 Mil from Dec. 2022 to Dec. 2023 .

Wanbangde Pharmaceutical Holding Group Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥916 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Wanbangde Pharmaceutical Holding Group Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 194.71.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Wanbangde Pharmaceutical Holding Group Co's liquidation value for the three months ended in Mar. 2024 was ¥-621 Mil.


Wanbangde Pharmaceutical Holding Group Co Change In Receivables Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Change In Receivables Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -501.34 -626.94 178.83 -101.79 -15.20

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Wanbangde Pharmaceutical Holding Group Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanbangde Pharmaceutical Holding Group Co  (SZSE:002082) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Wanbangde Pharmaceutical Holding Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=915.789/429.173*91
=194.71

2. In Ben Graham's calculation of liquidation value, Wanbangde Pharmaceutical Holding Group Co's accounts receivable are only considered to be worth 75% of book value:

Wanbangde Pharmaceutical Holding Group Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=192.238-1618.612+0.75 * 915.789+0.5 * 237.162
=-621

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanbangde Pharmaceutical Holding Group Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines